Mosanna Therapeutics raised €70M in a Series A round in Jun 2025. The company is based in Zurich, Switzerland. Investors in the round: Broadview Ventures, EQT Life Sciences, Forbion and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
